CompletedPhase 3

Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency

Australia, Austria161 participantsStarted 2002-02

Plain-language summary

This trial is conducted in Europe. Growth Hormone in young adults with growth hormone deficiency in childhood. This trial compares a treated group of patients with an untreated group of patients.

Who can participate

Age range18 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Child-hood onset growth hormone deficiency * Subjects received growth hormone replacement therapy during pre-puberty and puberty Exclusion Criteria: * GH treatment during the month preceding randomisation * Treatment within the previous 6 months with medication that may affect bone mineral density * Diseases which may affect bone metabolism

What they're measuring

Changes in bone mineralisation

Timeframe: After 2 years treatment

Trial details

NCT IDNCT00184678

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-07

View on ClinicalTrials.gov More Growth Hormone Disorder trials